Three retina specialists. One disease that used to be a conversation about waiting.

Three retina specialists. One disease that used to be a conversation about waiting. Murtaza Adam, MD, Ferhina Ali, MD, and Seenu Hariprasad, MD sat down for GA in Practice, a new iD Social roundtable on geographic atrophy: who to treat, when to start, and what it actually takes to keep patients coming back once the injections begin. They talk about the trial data, the 45 percent who stop by month 18, the month-six wall, and why the hardest part of treating GA is not the needle. Full conversation launches next week at idsocial.com. Editorially independent content produced with support from Astellas.